Ischemic Attack, Transient
36
3
4
23
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.3%
3 terminated out of 36 trials
88.5%
+2.0% vs benchmark
17%
6 trials in Phase 3/4
22%
5 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (36)
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Natural History of Stroke: Cause and Development
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave
Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital
Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke
Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA
Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, 2nd Wave
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study
Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
Pocket Sized Carotid Stenosis Screening by Junior Doctors
Connected Health Blood Pressure Monitoring In Stroke and TIA Patients
MIDNOR-TIA - a Study of 600 Patients With Transient Ischemic Attack
Pocket-size Cardiovascular Ultrasound in Stroke
Carotid Plaque Imaging in Acute Stroke
Biomarkers for the Diagnosis of Transient Ischemic Attack
Acute MRI in Transient Ischemic Attack
Does Positioning Effects on Early Postoperative Cognitive Dysfunction in Laparoscopic Oncological Surgery
An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in Vietnam
Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
Canadian Pradaxa Acute Stroke Safety Study